combination drug: levodopa / carbidopa

• CSA schedule: none
• DEA number: none
• MEDLINEplus^® Drug Information

U.S. Preparations:

• Carbidopa / Levodopa Tablets, USP (Endo Pharmaceuticals Inc.) FDA approved indications: treatment of idiopathic Parkinson's disease, postencephalitic Parkinsonism and Parkinsonism which may follow toxic injury
  U.S. Prescribing information
• Parcopa™ (Schwarz) FDA approved indications: treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic Parkinson's disease, and symptomatic Parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication.
  U.S. Prescribing information 8.30.2004
• Sinemet^® CR (Bristol-Myers Squibb) FDA approved indications: treatment of idiopathic Parkinson's disease, postencephalitic Parkinsonism and Parkinsonism which may follow toxic injury
  U.S. Prescribing information
• Sinemet^® (Bristol-Myers Squibb) FDA approved indications: treatment of idiopathic Parkinson's disease, postencephalitic Parkinsonism and Parkinsonism which may follow toxic injury U.S. Prescribing information
• Stalevo™ (Novartis) combination with entacapone

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2009 BehaveNet®